IE35608L - Phenylalkylamines - Google Patents
PhenylalkylaminesInfo
- Publication number
- IE35608L IE35608L IE710545A IE54571A IE35608L IE 35608 L IE35608 L IE 35608L IE 710545 A IE710545 A IE 710545A IE 54571 A IE54571 A IE 54571A IE 35608 L IE35608 L IE 35608L
- Authority
- IE
- Ireland
- Prior art keywords
- group
- carbon atoms
- hydroxyl
- atom
- alkyl group
- Prior art date
Links
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 230000002891 anorexigenic effect Effects 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008141 laxative Substances 0.000 abstract 1
- 229940125722 laxative agent Drugs 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C17/00—Preparation of halogenated hydrocarbons
- C07C17/26—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
- C07C17/32—Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by introduction of halogenated alkyl groups into ring compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/08—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms
- C07C205/09—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
- C07C45/562—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
- C07C45/565—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom by reaction with hexamethylene-tetramine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/64—Acyl halides
- C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1354451 Anorexigenic compositions BOEHRINGER INGELHEIM GmbH 30 April 1971 [2 May 1970] 12443/71 Heading A5B [Also in Division C2] Pharmaceutical compositions having good anorexigenic activity with only a slight central stimulating activity and low toxicity comprise halogen-substituted phenylalkylamine and their derivatives of the formula (I): wherein Cl represents a chlorine atom in the 4- or 6-position; R 1 , R 2 and R 3 , which may be the same or different, each represents a hydrogen atom or a methyl group; and R 4 represents a hydrogen atom, an alkyl group with 1 to 4 carbon atoms, or a benzyl or theophylline - (7) - ethyl group, the group -CH 2 -CH 2 -R 5 (wherein R 5 represents a carboxyl, alkoxycarbonyl, aminocarbonyl or cyano group), the group -CH 2 -CN, the group -(CH 2 ) m -R 6 or -C m H 2m-1 (C 6 H 5 )-R 6 (wherein m is 2, 3 or 4 and R 6 represents a halogen atom or a hydroxyl, amino or acylamino group), the group -C n H 2n -CO-R (wherein n is 1 or 2 and R represents an alkyl group with I to 4 carbon atoms or a phenyl group), or the group -CO-R 7 (wherein R 7 represents an alkoxy group with 1 to 4 carbon atoms, or an alkylthio or benzyloxy group or an alkyl group which may if desired be substituted by a halogen atom or a hydroxyl or amino group) and acid addition salts thereof in association with a pharmaceutical carrier or excipient, and if desired with other physiologically active ingredients, such as laxatives, in a form suitable for oral or rectal administration.
[GB1354451A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2021620A DE2021620C3 (en) | 1970-05-02 | 1970-05-02 | New phenylaminoalkanes and processes for their preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE35608L true IE35608L (en) | 1971-11-02 |
| IE35608B1 IE35608B1 (en) | 1976-03-31 |
Family
ID=5770113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE545/71A IE35608B1 (en) | 1970-05-02 | 1971-04-30 | Halogen-substituted phenylalkylamines and their derivatives |
Country Status (22)
| Country | Link |
|---|---|
| JP (4) | JPS5750773B1 (en) |
| AT (6) | AT317174B (en) |
| BE (1) | BE766654A (en) |
| BG (5) | BG19131A3 (en) |
| CH (4) | CH579023A5 (en) |
| CS (3) | CS170545B2 (en) |
| DE (1) | DE2021620C3 (en) |
| ES (4) | ES390778A1 (en) |
| FI (1) | FI53571C (en) |
| FR (1) | FR2092123B1 (en) |
| GB (1) | GB1354451A (en) |
| HU (1) | HU162545B (en) |
| IE (1) | IE35608B1 (en) |
| IL (1) | IL36743A (en) |
| NL (1) | NL169462C (en) |
| NO (1) | NO133708C (en) |
| PL (3) | PL91964B1 (en) |
| RO (5) | RO57814A (en) |
| SE (1) | SE374355B (en) |
| SU (3) | SU439963A3 (en) |
| YU (6) | YU35571B (en) |
| ZA (1) | ZA712788B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2239012A1 (en) * | 1972-08-08 | 1974-02-21 | Knoll Ag | BASIC SUBSTITUTED THEOPHYLLINE COMPOUNDS |
| NZ210420A (en) * | 1983-12-06 | 1988-04-29 | Merrell Dow Pharma | D-amino acid oxidase substrates and pharmaceutical compositions |
| JPS6314015U (en) * | 1986-07-11 | 1988-01-29 | ||
| JPS63136497A (en) * | 1986-11-28 | 1988-06-08 | Hitachi Medical Corp | X-ray device |
| JPH0378128U (en) * | 1989-11-30 | 1991-08-07 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2029385A1 (en) * | 1969-01-27 | 1970-10-23 | Science Union & Cie |
-
1970
- 1970-05-02 DE DE2021620A patent/DE2021620C3/en not_active Expired
-
1971
- 1971-04-28 SU SU1820124A patent/SU439963A3/en active
- 1971-04-28 RO RO66747A patent/RO57814A/ro unknown
- 1971-04-28 SU SU1820134A patent/SU440824A3/ru active
- 1971-04-28 RO RO7100070105A patent/RO62418A/en unknown
- 1971-04-28 RO RO70106A patent/RO57681A/ro unknown
- 1971-04-28 RO RO7100070107A patent/RO62296A/en unknown
- 1971-04-28 RO RO70104A patent/RO57821A/ro unknown
- 1971-04-28 SU SU1649251A patent/SU398031A3/ru active
- 1971-04-29 CS CS3115A patent/CS170545B2/cs unknown
- 1971-04-29 CH CH29975A patent/CH579023A5/xx not_active IP Right Cessation
- 1971-04-29 YU YU1080/71A patent/YU35571B/en unknown
- 1971-04-29 CS CS2325A patent/CS175428B2/cs unknown
- 1971-04-29 CH CH29775A patent/CH570968A5/xx not_active IP Right Cessation
- 1971-04-29 CH CH29875A patent/CH579022A5/xx not_active IP Right Cessation
- 1971-04-29 CS CS722324A patent/CS194665B2/en unknown
- 1971-04-29 CH CH632271A patent/CH561169A5/xx not_active IP Right Cessation
- 1971-04-29 NL NLAANVRAGE7105946,A patent/NL169462C/en not_active IP Right Cessation
- 1971-04-30 NO NO1615/71A patent/NO133708C/no unknown
- 1971-04-30 ZA ZA712788A patent/ZA712788B/en unknown
- 1971-04-30 HU HUBO1290A patent/HU162545B/hu unknown
- 1971-04-30 ES ES390778A patent/ES390778A1/en not_active Expired
- 1971-04-30 BG BG019047A patent/BG19131A3/en unknown
- 1971-04-30 FR FR7115627A patent/FR2092123B1/fr not_active Expired
- 1971-04-30 AT AT518473A patent/AT317174B/en active
- 1971-04-30 BG BG22776A patent/BG21017A3/xx unknown
- 1971-04-30 AT AT518573A patent/AT317175B/en not_active IP Right Cessation
- 1971-04-30 AT AT518673A patent/AT317176B/en not_active IP Right Cessation
- 1971-04-30 AT AT375071A patent/AT317171B/en active
- 1971-04-30 IE IE545/71A patent/IE35608B1/en unknown
- 1971-04-30 PL PL1971177491A patent/PL91964B1/pl unknown
- 1971-04-30 BG BG019045A patent/BG19589A3/en unknown
- 1971-04-30 BG BG017446A patent/BG18601A3/en unknown
- 1971-04-30 PL PL1971147865A patent/PL85189B1/pl unknown
- 1971-04-30 SE SE7105652A patent/SE374355B/xx unknown
- 1971-04-30 PL PL1971177492A patent/PL90714B1/pl unknown
- 1971-04-30 GB GB1244371A patent/GB1354451A/en not_active Expired
- 1971-04-30 FI FI1212/71A patent/FI53571C/en active
- 1971-04-30 BG BG019046A patent/BG21016A3/en unknown
- 1971-04-30 IL IL36743A patent/IL36743A/en unknown
- 1971-04-30 AT AT518373A patent/AT317173B/en not_active IP Right Cessation
- 1971-04-30 AT AT518273A patent/AT317172B/en not_active IP Right Cessation
- 1971-05-01 JP JP46029370A patent/JPS5750773B1/ja active Pending
- 1971-05-03 BE BE766654A patent/BE766654A/en not_active IP Right Cessation
-
1972
- 1972-05-12 ES ES402638A patent/ES402638A1/en not_active Expired
- 1972-05-12 ES ES402636A patent/ES402636A1/en not_active Expired
- 1972-05-12 ES ES402637A patent/ES402637A1/en not_active Expired
-
1978
- 1978-10-26 YU YU2498/78A patent/YU36285B/en unknown
- 1978-10-26 YU YU02500/78A patent/YU36482B/en unknown
- 1978-10-26 YU YU2499/78A patent/YU36286B/en unknown
-
1980
- 1980-06-16 YU YU1590/80A patent/YU37114B/en unknown
- 1980-09-17 JP JP55129028A patent/JPS589090B2/en not_active Expired
- 1980-09-17 JP JP12902780A patent/JPS5655350A/en active Granted
- 1980-09-17 JP JP12902980A patent/JPS5655352A/en active Granted
-
1981
- 1981-02-20 YU YU00433/81A patent/YU43381A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR970704435A (en) | Use of Heterocyclic Compounds as Dopamine-D Ligands (Use of Heterocyclic Compounds as Dopamine-D Ligands) | |
| KR920008026A (en) | Isoquinolinone derivatives or nontoxic acid addition salts thereof or hydrates thereof, methods for preparing the same, and pharmaceutical compositions comprising the same | |
| ES8603870A1 (en) | Derivatives of 2,2'-iminobisethanol. | |
| NO810479L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED IMIDAZOLD DERIVATIVES | |
| NO158017C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES. | |
| IE35608B1 (en) | Halogen-substituted phenylalkylamines and their derivatives | |
| FR2699176B1 (en) | New bicyclic pyrimidine compounds, process for their preparation and pharmaceutical compositions containing them. | |
| KR900018100A (en) | 2,3-d | |
| DE3785463D1 (en) | PHARMACOLOGICALLY ACTIVE ALKYLOL DERIVATIVES. | |
| KR880009943A (en) | Pyridazinone derivatives | |
| GB1497729A (en) | Benzenesulphonyl ureas and process for their manufacture | |
| FI853866L (en) | 2-PYRIDIN-THIOL DERIVATIVES, FOERFARANDE FOER FRAMSTAELLNING AV DESSA SAMT PHARMACEUTICAL FOERENINGAR INNEHAOLLANDE DESSA. | |
| IE800541L (en) | Ergolines | |
| GB1451423A (en) | 1-oxo-1h-6-substituted pyrimido-1,2-a-quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents | |
| EP0325044A3 (en) | Pharmacologically active cyclic peptide | |
| IE893258L (en) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them | |
| KR880011163A (en) | 4- benzyl- piperazinyl hydrazone | |
| EP0355169A4 (en) | Antianxiety drug | |
| FR2572074B1 (en) | THIADIAZOLE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| EP0461264A4 (en) | Ethynylphenyl derivative, production thereof, and remedy for diseases of circulatory organs containing the same as active ingredient | |
| GB1054278A (en) | Pharmaceutical preparations having hypoglycaemic properties | |
| GB1384523A (en) | Oxime derivatives and their preparation | |
| KR880001630A (en) | 5-fluorouracil derivatives and uses thereof | |
| GB1362400A (en) | 1-amino-isoquinoline derivatives | |
| AU566722B2 (en) | Pyrimido(1,6-alpha)indole-5-acetic acids |